FW: PNH

From: Abby Kelliher (allena@helix.mgh.harvard.edu)
Date: Thu Jan 13 2000 - 10:54:59 EST


Thomas Nebe sent me some relevant PNH information that was also very 
helpful.  I am posting his response below:

-----Original Message-----
From:	Nebe, Thomas C. [SMTP:thomas.nebe@ikc.ma.uni-heidelberg.de]
Sent:	Thursday, January 13, 2000 10:42 AM
To:	'allena@helix.mgh.harvard.edu'
Subject:	PNH

Dear Abby Kelliher,

I appreciate that you brought up the problems in the diagnosis of PNH. 
 However, as it is a severe diagnosis and almost made by flow and most 
often in a phase without  clinical signs you need to be very careful.  I 
guess you know the consequences of prevalence in terms of sensitivity and 
specificity of a test.
I think your summary might be more confusing than helpful as it doesn?t 
point to the problems.  CD14 is extremely difficult because of the problems 
to define monocytes. The redundancy and check of the different lineages is 
esp. important.
You may look at our website to check the arguments:
http://www.ma.uni-heidelberg.de/inst/ikc/pnhengl.htm
We made our mistakes as well when we started but we learned esp. from the 
experts like Dr. Schrezenmeier.
Regards
Thomas Nebe

Dr.med. C. Thomas Nebe
Universitaetsklinikum Mannheim
Zentrallabor
Theodor-Kutzer-Ufer 1-3
D-68167 Mannheim
Tel.  +49 621 383-3485
FAX  +49 621 383-73 3485
+49 621 383-3819
e-mail: thomas.nebe@ikc.ma.uni-heidelberg.de
Bitte besuchen Sie unsere informativen Webseiten unter
http://www.ma.uni-heidelberg.de/inst/ikc/



This archive was generated by hypermail 2b29 : Sat Mar 10 2001 - 19:31:03 EST